However, the role of KRAS mutations in the early diagnosis of pancreatic carcinoma remains controversial35, because the diagnostic sensitivity of KRAS analysis is low (35–38%)13,36. The gene discussed is KRAS; the disease is exocrine pancreatic carcinoma.